Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
Mahmudul Hasan, Md. Sorwer Alam Parvez, Kazi Faizul Azim, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111742-111742
Open Access | Times Cited: 23

Showing 23 citing articles:

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach
Kazi Faizul Azim, Sheikh Rashel Ahmed, Anik Banik, et al.
Informatics in Medicine Unlocked (2020) Vol. 20, pp. 100367-100367
Open Access | Times Cited: 74
Acute Cerebellar Inflammation and Related Ataxia: Mechanisms and Pathophysiology
Md. Sorwer Alam Parvez, Gen Ohtsuki
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 367-367
Open Access | Times Cited: 22
Drug repurposing against SARS-CoV-2 using computational approaches
Sumit Kumar, Svitlana Kovalenko, Shakshi Bhardwaj, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 2015-2027
Open Access | Times Cited: 21
Artificial intelligence based methods for hot spot prediction
Damla Ovek, Zeynep Abali, Melisa Ece Zeylan, et al.
Current Opinion in Structural Biology (2021) Vol. 72, pp. 209-218
Closed Access | Times Cited: 29
Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-CoV-2
Wenzhu Zhao, Xin Li, Zhipeng Yu, et al.
LWT (2021) Vol. 154, pp. 112684-112684
Open Access | Times Cited: 26
Identification of 4-acrylamido-N-(pyridazin-3-yl)benzamide as anti-COVID-19 compound: a DFTB, molecular docking, and molecular dynamics study
Nayim Sepay, Sukanya Chakrabarti, Mohd Afzal, et al.
RSC Advances (2022) Vol. 12, Iss. 37, pp. 24178-24186
Open Access | Times Cited: 18
Fullerenes against COVID-19: Repurposing C60 and C70 to Clog the Active Site of SARS-CoV-2 Protease
Tainah Dorina Marforio, Edoardo Jun Mattioli, Francesco Zerbetto, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1916-1916
Open Access | Times Cited: 16
Potential of umami molecules against SARS-CoV-2 (Omicron) S-RBD/hACE2 interaction: an in-silico study
Zhiyong Cui, Shengnan Wang, Yeling Xu, et al.
Journal of Future Foods (2024) Vol. 5, Iss. 3, pp. 283-294
Closed Access | Times Cited: 2
Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach
Nahid Shahabadi, Saba Zendehcheshm, Mohammad Mahdavi, et al.
Informatics in Medicine Unlocked (2021) Vol. 26, pp. 100745-100745
Open Access | Times Cited: 14
De Novo design of potential inhibitors against SARS-CoV-2 Mpro
Shimeng Li, Lianxin Wang, Jinhui Meng, et al.
Computers in Biology and Medicine (2022) Vol. 147, pp. 105728-105728
Open Access | Times Cited: 10
Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
(2024)
Open Access | Times Cited: 1
Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2
Tofael Ahmed Sumon, Md. Ashraf Hussain, Mahmudul Hasan, et al.
Aquaculture (2021) Vol. 541, pp. 736783-736783
Open Access | Times Cited: 10
Identification of Promising Sulfonamide Chalcones as Inhibitors of SARS-CoV-2 3CLpro through Structure-Based Virtual Screening and Experimental Approaches
Piyatida Pojtanadithee, Kowit Hengphasatporn, Aphinya Suroengrit, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5244-5258
Closed Access | Times Cited: 3
Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2
Shilpa Sharma, Ashish Sharma, Dipto Bhattacharyya, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 24, pp. 14096-14114
Closed Access | Times Cited: 7
Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides
Marjoriane de Amaral, Julia Ienes-Lima
Virus Research (2022) Vol. 315, pp. 198769-198769
Open Access | Times Cited: 4
Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 825-852
Open Access
Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs
Valentina L. Kouznetsova, David Z Huang, Igor F. Tsigelny
Physical Biology (2020) Vol. 18, Iss. 2, pp. 025001-025001
Closed Access | Times Cited: 5
In silico screening of potential inhibitor from Andrographis paniculata constituents against three targets of SARS-CoV-2: Main protease, Spike protein, and Nsp15
Panita Kongsune, Wansiri Innok, Thanyada Rungrotmongkol
ASEAN Journal of Scientific and Technological Reports (2022) Vol. 25, Iss. 1, pp. 69-76
Open Access | Times Cited: 3
The efficacy of combined therapy of qingfeiPaidu capsule and lianhuaqingwen capsule nursing interventions for hospitalized patients with COVID-19: A retrospective study of medical records
Yan Li, Wenhan Yu, Jinxia Zhai, et al.
Medicine (2022) Vol. 101, Iss. 32, pp. e29964-e29964
Open Access | Times Cited: 2
Virtual Screening through Molecular Docking Analysis to Identify Potential Natural Inhibitor(s) of Lyn Tyrosine Kinase- An In-silico Approach
Sohini Kulavi, Soham Banerjee, Titav Sengupta, et al.
Journal of Pharmaceutical Research International (2021), pp. 85-105
Open Access | Times Cited: 2
Small Molecule Inhibitors Targeting Methyltransferase-Like (METTL) Proteins Against Hepatocellular Carcinoma: A Comprehensive Drug Repurposing Approach
Md Niaz Morshed, Md. Sorwer Alam Parvez, Rakibul Islam Akanda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A Narrative Review: Molecular Docking Simulation of Antiviral Drugs as Anti-COVID-19 Candidates
Muchtaridi Muchtaridi, Adham Rizki Ananda, Fajri Raihan, et al.
Research Journal of Pharmacy and Technology (2023), pp. 3031-3037
Closed Access
Computational approaches for identifying bioactive compounds inhibiting SARS-CoV-2 main protease
Piyatida Pojtanadithee
(2022)
Open Access
Page 1

Scroll to top